The bladder adenocarcinoma cell line T24 and the pancreatic adenocarcinoma cell line Mia-Paca2 showed induction of E-cadherin promoter activity upon nintedanib treatment (Figure 7B). This evidence concerns the gene CDH1 and pancreatic adenocarcinoma.